Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Weill Medical College of Cornell University |
---|---|
Information provided by: | Weill Medical College of Cornell University |
ClinicalTrials.gov Identifier: | NCT00504894 |
This study involves 54 healthy volunteers aged between 18 and 50 recruited from the general community. It involves doing a set of simple memory tests while inside a fMRI machine. The subject is given a very low dose of an anesthetic drug intravenously while in the scanner. The subject then sees a sequence of pictures on a screen, and presses a button if they remember seeing the picture before. While this is happening, the scanner will be capturing images that tell us what parts of the brain are active. Hypothesis: patterns of hippocampal and amygdala activation during the encoding and retrieval of memory,as measured by fMRI, will be altered by intravenous anesthetics such that suppression of hippocampal and amygdala activities will be dissociable. This dissociation pattern will be different between the drugs propofol and thiopental
Condition | Intervention | Phase |
---|---|---|
Healthy |
Drug: Thiopental Drug: Propofol |
Phase IV |
Study Type: | Interventional |
Study Design: | Randomized, Single Blind (Subject), Parallel Assignment |
Official Title: | Neuroimaging the Effects of Intravenous Anesthetic on Amygdala Dependent Memory Processes |
Estimated Enrollment: | 90 |
Study Start Date: | March 2007 |
Estimated Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
A: Placebo Comparator
Drug given in low dose to gauge subject's responses to visual stimuli.
|
Drug: Thiopental
A low dose given intravenously one time for just under an hour while the subject is shown visually stimulating images in an MRI machine.
|
B: Placebo Comparator
Thiopental administration
|
Drug: Propofol
A low dose given intravenously while the subject is shown visually stimulating images in an MRI machine.
|
Ages Eligible for Study: | 18 Years to 50 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Jackie Bogan, BA | 212-746-2952 | jab2035@med.cornell.edu |
Contact: Kane Pryor, M.D. |
United States, New York | |
Weill Cornell Medical College | Recruiting |
New York, New York, United States, 10065 | |
Principal Investigator: Kane Pryor, M.D. |
Principal Investigator: | Kane Pryor, M.D. | Weill Cornell Medical College |
Responsible Party: | WCMC ( Kane Pryor, MD ) |
Study ID Numbers: | 0701008933 |
Study First Received: | July 19, 2007 |
Last Updated: | March 20, 2008 |
ClinicalTrials.gov Identifier: | NCT00504894 History of Changes |
Health Authority: | United States: Institutional Review Board |
N/A healthy volunteers |
Anesthetics, Intravenous Neurotransmitter Agents Anesthetics, General Thiopental Hypnotics and Sedatives |
Central Nervous System Depressants Anesthetics Healthy Propofol Anticonvulsants |
Anesthetics, Intravenous Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Thiopental GABA Modulators Physiological Effects of Drugs Anesthetics Central Nervous System Depressants |
Pharmacologic Actions Anesthetics, General Therapeutic Uses Hypnotics and Sedatives GABA Agents Central Nervous System Agents Anticonvulsants |